(S)-(3-((7-(benzylamino)-3-isopropylpyrazolo[1,5-a]pyrimidin-5-ylamino)methyl)pyrrolidin-3-yl)methanol

ID: ALA4553241

PubChem CID: 155555568

Max Phase: Preclinical

Molecular Formula: C22H30N6O

Molecular Weight: 394.52

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(C)c1cnn2c(NCc3ccccc3)cc(NC[C@]3(CO)CCNC3)nc12

Standard InChI:  InChI=1S/C22H30N6O/c1-16(2)18-12-26-28-20(24-11-17-6-4-3-5-7-17)10-19(27-21(18)28)25-14-22(15-29)8-9-23-13-22/h3-7,10,12,16,23-24,29H,8-9,11,13-15H2,1-2H3,(H,25,27)/t22-/m0/s1

Standard InChI Key:  AUZGEDPWRMYCLE-QFIPXVFZSA-N

Molfile:  

 
     RDKit          2D

 29 32  0  0  0  0  0  0  0  0999 V2000
   22.6575   -7.5611    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.3706   -7.1546    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.0812   -7.5652    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   24.7942   -7.1587    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.5016   -7.5723    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   25.5087   -5.9306    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.7916   -6.3394    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.2192   -6.3476    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   26.2127   -7.1686    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.9918   -7.4272    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.4773   -6.7659    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.0022   -6.1013    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   25.5139   -5.1093    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   24.8046   -4.6962    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.8098   -3.8749    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.5239   -3.4712    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.5294   -2.6507    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.8197   -2.2368    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.1029   -2.6453    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.1009   -3.4645    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.9838   -8.2462    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.2680   -8.6520    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.6916   -8.6659    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.9092   -7.2321    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.3606   -7.8419    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.7672   -8.5550    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.5711   -8.3832    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.6502   -6.7398    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.9348   -6.3375    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  1
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  7  1  0
  5  9  1  0
  8  6  1  0
  6  7  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  8  1  0
  6 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 15  1  0
 10 21  1  0
 21 22  1  0
 21 23  1  0
  1 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27  1  1  0
  1 28  1  0
 28 29  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4553241

    ---

Associated Targets(Human)

CCNH Tbio CDK7/Cyclin H/MNAT1 (693 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CDK1 Tchem Cyclin-dependent kinase 1 (3927 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCNE1 Tchem Cyclin-dependent kinase 2/cyclin E1 (1877 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 394.52Molecular Weight (Monoisotopic): 394.2481AlogP: 2.85#Rotatable Bonds: 8
Polar Surface Area: 86.51Molecular Species: BASEHBA: 7HBD: 4
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 10.46CX LogP: 2.16CX LogD: -0.68
Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.47Np Likeness Score: -0.74

References

1. Teng Y, Lu K, Zhang Q, Zhao L, Huang Y, Ingarra AM, Galons H, Li T, Cui S, Yu P, Oumata N..  (2019)  Recent advances in the development of cyclin-dependent kinase 7 inhibitors.,  183  [PMID:31514062] [10.1016/j.ejmech.2019.111641]

Source